InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
1 hedge funds and large institutions have $0 invested in InspireMD, Inc. Warrants in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$71 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1K |
NSPRW Hedge Fund Activity: Q4 2018 in Review
1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q4 2018, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NSPRW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $71. The largest seller was Sabby Management, exiting entirely with an estimated $1K sold.
- 1 institutional investor held InspireMD, Inc. Warrants (NSPRW) as of Q4 2018, down from 2 in Q3 2018.
- Funds reported $0 of InspireMD, Inc. Warrants stock for Q4 2018, down 100% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q4 2018 and 1 closed out, a net change of -1 holder.
- The largest InspireMD, Inc. Warrants buyer in Q4 2018 was UBS Group, an estimated $71 added.
- The largest InspireMD, Inc. Warrants seller in Q4 2018 was Sabby Management, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2018.